Sodium Polystyrene Sulfonate
NDC 46287-006, sodium polystyrene sulfonate, suspension, from CMP Pharma, Inc..
- Product NDC
- 46287-006
- Status
- Listed
- Labeler
- CMP Pharma, Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL, RECTAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA087859
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/46287-006 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM POLYSTYRENE SULFONATE15 g/60mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 46287-006-01 | 46287000601 | 473 mL in 1 BOTTLE (46287-006-01) |
| 46287-006-04 | 46287000604 | 120 mL in 1 BOTTLE (46287-006-04) |
| 46287-006-60 | 46287000660 | 10 BOTTLE, UNIT-DOSE in 1 CARTON (46287-006-60) / 60 mL in 1 BOTTLE, UNIT-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/12d48dcf-07bd-4b06-bd6c-7543f1be8357NADAC price for package 46287000601
GET /v1/drugs/nadac/46287000601NADAC price for package 46287000660
GET /v1/drugs/nadac/46287000660
Use it
Look up 46287-006 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/46287-006 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 46287-006. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.